Results 171 to 180 of about 177,348 (250)

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): diagnosis and management. [PDF]

J Transl Med
Fan J, Jiao J, Chang HQ, Zhong DL, Liu XB, Li J, Chen LM, Jin RJ, Wu X.   +8 more
europepmc   +1 more source

Outcomes in the Management of Pediatric Retrograde Cricopharyngeal Dysfunction

The Laryngoscope, EarlyView.
ABSTRACT Objective To review the presentation and treatment outcomes of pediatric patients with retrograde cricopharyngeal dysfunction (RCPD). Methods A retrospective chart review was performed on pediatric patients diagnosed with retrograde cricopharyngeal dysfunction (RCPD) and treated with cricopharyngeal botulinum toxin injection (CPBTI).
Aidan P. Wright, Vivian Jin, Nathaniel B. Hunter, Andrew G. Tritter   +3 more
wiley   +1 more source

Human Endogenous Retroviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Emerging Roles in Pathogenesis, Immunity, Biomarkers and Therapeutics. [PDF]

Int J Mol Sci
Perera KD, Oltra E, Carding SR.
europepmc   +1 more source

Validation of the TruBlue Light Laser for Laryngeal Somatosensory and Perturbation Testing

The Laryngoscope, EarlyView.
This study validates a blue light laser method for assessing laryngeal somatosensory function by measuring perceptual thresholds, reflexive responses, discrimination acuity, and vocal perturbations in healthy adults. Results demonstrate that the method provides precise, reliable stimulation and yields quantifiable sensory and acoustic responses ...
Adrianna C. Shembel, Ted Mau, Youri Maryn, Elizabeth Young, Julianna Smeltzer, Lesley Childs, Shumon Dhar   +6 more
wiley   +1 more source

Mucosal Viruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Missing Piece of the Puzzle? [PDF]

Int J Mol Sci
Perera KD, Cameron P, Sarwar T, Carding SR.   +3 more
europepmc   +1 more source

Laryngeal Dysfunction Following COVID‐19: A TriNetX Retrospective Cohort Study

The Laryngoscope, EarlyView.
COVID‐19 is associated with an increased incidence of new‐onset laryngeal dysfunction, including chronic cough, dysphagia, voice disorders, vocal fold paralysis, and laryngeal spasm, compared with uninfected controls. Risk peaks one to two years after infection for most outcomes and is influenced by factors such as hospitalization, mechanical ...
Cali Loblundo, Warren B. Chun, Shaun A. Nguyen, Kirsten Meenan, Ashli K. O'Rourke   +4 more
wiley   +1 more source

Toward a Molecular Reclassification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Integrating Multi-Omics, Machine Learning, and Precision Medicine. [PDF]

Int J Mol Sci
Frank J, Nesterovitch N, Movva C, Klimas NG, Nathanson L.   +4 more
europepmc   +1 more source

Pregabalin Efficacy in Treatment of Chronic Neurogenic Cough

The Laryngoscope, EarlyView.
The use of neuromodulators for chronic cough has increased; however, the choice of medication, dosing regimen, and duration are still unclear. This longitudinal study of 95 adults taking pregabalin, 75 mg twice daily, for CNC demonstrated 78% improvement or resolution of cough, 17% unchanged, 1% worse cough, with a mean of 6 weeks of therapy, and only ...
Jacqui Allen, Carmen Esna, Camille Prigent, Anna Miles   +3 more
wiley   +1 more source

Alterations in gut microbiota and associated metabolites in patients with chronic fatigue syndrome. [PDF]

Sci Rep
Cheng X, Wang W, Xu T, Wang Y, Zhen X, Man W, Gao S, Yin Y.   +7 more
europepmc   +1 more source